Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$494.46 USD
-11.32 (-2.24%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $494.52 +0.06 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (91 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.80 | 1.35 | 9.99 |
Current Quarter Estimate | 3.98 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 4.08 | 0.12 | 54.84 |
Next Quarter Estimate | 3.93 | 7.81 | 63.00 |
Next Year Estimate | 17.73 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -89.17 | 16.20 | 15.67 |
Next Year | 974.55 | 10.00 | 11.34 |
Last 5 Years | 38.20 | 1.00 | 8.10 |
Next 5 Years | 12.80 | 20.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 2,354.57 | -2.18 |
Price/Book (MRQ) | 8.64 | 2.20 |
Price/Cash Flow (MRFY) | 33.74 | 16.91 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -4.74% | -12.31% |
Return on Equity (TTM) | -2.45% | -15.05% |
Debt to Equity (MRQ) | 0.02 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.